相关实验视频

Updated: Jan 9, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

探索NS5甲基转移酶向药物发现的先进方法

Tomáš Otava¹, Matúš Drexler¹, Petra Krafčíková¹

¹Institute of Organic Chemistry and Biochemistry CAS, v.v.i., Gilead Sciences Research Centre at IOCB Prague, Flemingovo nam. 2., Prague 6, 166 10, Czech Republic.

European journal of medicinal chemistry

|November 30, 2025

概括

开发新的抗病毒药物需要有效的登革热病毒NS5甲基转移酶抑制剂. 这项研究提出了一种经过验证的综合查策略,使用光极化,NMR和声学质谱来识别强效抑制剂.

科学领域:

生物化学生化学
病毒学病毒学
药物发现药物发现药物发现

背景情况:

新兴的病毒病原体需要针对性的抗病毒疗法.
登革热病毒NS5甲基转移酶对于病毒RNA封闭和免疫逃避至关重要,使其成为治疗点.
强大的测试的有限可用性阻碍了对这种酶的小分子抑制剂的发现.

研究的目的:

解决对有效登革热病毒NS5甲基转移酶抑制剂的需求.
为了比较评估三个直角的抑制剂识别和表征的方法.
为开发新型抗病毒药物制定综合查策略.

主要方法:

合成30个S-adenosylhomocysteine类似物,使用铜催化酸基因循环添加.
查抑制剂使用光极化 (连接体位移),NMR定位 (残留特异性相互作用) 和声学质谱法 (无标签的酶定量).
对测试性能和抑制剂强度排名的比较分析.

主要成果:

在所有三个直角测试平台上都观察到一致的强度排名.
光极化使得初始抑制剂分类的高通量选成为可能.
核磁共振为联体酶相互作用提供了关键的结构洞察力,声学质谱证实了功能抑制.
综合方法验证了NS5甲基转移酶抑制剂的合理开发.

结论:

一个集成的模块化查策略有效地识别和表征登革热病毒NS5甲基转移酶抑制剂.
这种方法促进了强效抗病毒化合物的合理设计.
该方法可适应针对其他病毒或生物体中的相关RNA封闭酶.

更多相关视频

Sequence-specific Labeling of Nucleic Acids and Proteins with Methyltransferases and Cofactor Analogues

Sequence-specific Labeling of Nucleic Acids and Proteins with Methyltransferases and Cofactor Analogues

Published on: November 22, 2014

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells

Published on: August 7, 2021

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...